RecruitingNCT06987474

Capella Scientia Development Study

Capella Scientia (SCDX) Development Study

Sponsor

Alcon Research

Enrollment

400 participants

Start Date

Jul 30, 2025

Study Type

OBSERVATIONAL

Conditions

Cataract

Summary

This study involves collecting biometry and aberration data using the next generation biometer, Unity DX.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Argos with Alcon Image Guidance Biometer, a medical device called IOLMaster 700 Biometer, and others for people with cataract. The study is currently recruiting participants at 4 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEUnity DX and SMARTCataract DX (SCDX) Biometer

Unity DX is a CE-marked, noninvasive, noncontact instrument that generates a 3D model of the eye using hyper parallel optical coherence tomography (HP OCT), aberrometry, and topography. The current version of SCDX software will be used in this study.

DEVICEIOLMaster 700 Biometer

The IOLMaster 700 Biometer is a CE-marked, noninvasive, noncontact instrument that captures optical biometry. Data will be collected using standard clinical assessments.

DEVICEArgos with Alcon Image Guidance Biometer

The Argos with Alcon Image Guidance biometer is a CE-marked, noninvasive, noncontact instrument that will capture optical biometry. Data will be collected using standard clinical assessments.